You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 116 No. 10, October 1981 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  FESTSCHRIFT TO DR SAMUEL R. POWERS, JR
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Pancreatic Polypeptide

A Review

Janos Lonovics, MD; Peter Devitt, FRCS; Larry C. Watson, MD; Phillip L. Rayford, PhD; James C. Thompson, MD

Arch Surg. 1981;116(10):1256-1264.


Abstract



• Pancreatic polypeptide (PP), a 36-amino acid peptide, may function as an important feedback inhibitor of pancreatic secretion after a meal. It arises from both islet and acinar cells of the pancreas. Release of PP by a meal, primarily protein, occurs in a biphasic manner. The first rapid release occurs as a result of vagal stimulation; the second, more prolonged rise (the so-called intestinal phase) occurs in response to hormonal stimulation, predominantly cholecystokinin. Plasma PP levels increase with age; PP levels are elevated above those of age-controlled normal subjects in diabetic patients and in some patients with pancreatic amine precursor uptake decarboxylase tumors. The value of plasma PP as a possible marker for pancreatic tumors is as yet unsettled but may be a valuable tool.

(Arch Surg 1981;116:1256-1264)



Author Affiliations



From the Department of Surgery, The University of Texas Medical Branch, Galveston (Drs Lonovics, Watson, Rayford, and Thompson and Mr Devitt); Szeged University Medical School, Hungary (Dr Lonovics); and University of Bristol, England (Mr Devitt). Mr Devitt is now with Liverpool Royal Hospital, England, and Dr Rayford is now with The University of Arkansas School of Medicine, Little Rock.


Footnotes



Accepted for publication June 5, 1981.

Reprint requests to Department of Surgery, The University of Texas Medical Branch, Galveston, TX 77550 (Dr Thompson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multihormonal Pancreatic Endocrine Tumor in a Dog with Duodenal Ulcers and Hypertrophic Gastropathy
Boosinger et al.
Veterinary Pathology 1988;25:237-239.
 

Studies on Segmental Pancreatic Autotransplants in Dogs
Munda et al.
Arch Surg 1983;118:1310-1315.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.